Drug Trial Radar · NCT03275922
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Last checked: Nov 20, 2026Latest source record: Jan 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
374
Actual
Start
Nov 27, 2017
Primary completion
Jul 2, 2020
Study completion Sep 28, 2020
Sponsor
- Lead sponsor
- Impax Laboratories, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Sep 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Part 1: Approximately 20 weeks (includes screening and double-blind treatment). * Screening will be performed based on the inclusion exclusion criteria specified in the study protocol. * Randomize approximately 288 subjects into the double-blind crossover phase. Part 2: Approximately 100 subjects who complete the double-blind crossover phase will enter part 2, a 6 month open-label safety extension (OLE). Efficacy will be evaluated in the double-blind part of the trial. Safety will be evaluated in both the double-blind and the OLE.
Conditions
- Migraine
Interventions
Placebo ZNSDrug
Placebo Zolmitriptan Nasal Spray
ZNSDrug
Zolmitriptan Nasal Spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain-free status at 2 hours post treatmentTime frame: 2 hours post-dose
Locations
47 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Children's Hospital (149)
Phoenix, Arizona
Arkansas Children's Hospital (109)
Little Rock, Arkansas
Advanced Research Center, Inc (134)
Anaheim, California
Sierra Medical Research (124)
Fresno, California
Shailesh M. Asaikar, MD. Inc. DBA Child and Adolescent Neurology Consultatns (119)
Sacramento, California
Children's Hospital Colorado (154)
Aurora, Colorado
Blue Sky Neurology (106)
Englewood, Colorado
IMMUNOe Research Centers (150)
Thornton, Colorado
Ki Health Partners, LLC dba New England INstitute for Clinical Research (128)
Stamford, Connecticut
Children's National Health System (141)
Washington D.C., District of Columbia
NW Florida Clinical Research Group, LLC (122)
Gulf Breeze, Florida
Clinical Neuroscience Solutions, Inc. (127)
Jacksonville, Florida
Axcess Medical Research (126)
Loxahatchee Groves, Florida
Biotech Pharmaceutical Group (138)
Miami, Florida
Sanitas Medical and Dental Institute/dba Sanitas Research, LLC (142)
Miami, Florida
Laszlo J. Mate, M.D., P.A. (153)
North Palm Beach, Florida
Clincial Neuroscience Solutions, Inc. (136)
Orlando, Florida
Pediatric Neurology, PA (125)
Orlando, Florida
East Florida Research (143)
Port Saint Lucie, Florida
Pedatric Epilepsy & Neurology Specialists (157)
Tampa, Florida
Premiere Research Institute @ Palm Beach Neurology, PA (105)
West Palm Beach, Florida
Clinical Integrative Research Center of Atlanta (121)
Atlanta, Georgia
NuDirections Clinical Research, LLC (159)
Atlanta, Georgia
iResearch Atlanta, LLC (146)
Decatur, Georgia
Meridian Clinical Research, LLC (130)
Savannah, Georgia
Josephson Wallack Munshower Neurology P.C. (114)
Indianapolis, Indiana
Kosair Charities Pediatric Clinical Research Unit (120)
Louisville, Kentucky
Michigan Head-Pain and Neurological Institute (103)
Ann Arbor, Michigan
Mercy Research (116)
St Louis, Missouri
Clinical Research Center of NJ (123)
Voorhees Township, New Jersey
Dent Neurosciences Research Center (129)
Amherst, New York
OnSite Clinical Solutions, LLC (155)
Charlotte, North Carolina
Headache Wellness Center (Site 152)
Greensboro, North Carolina
Raleigh Neurology Associates, PA (113)
Raleigh, North Carolina
Akron Children's Hospital (site 139)
Akron, Ohio
Cincinnati Children's Hospital (140)
Cincinnati, Ohio
Preferred Primary Care Physicians, Inc. (115)
Pittsburgh, Pennsylvania
Access Clinical Trials, Inc. (151)
Nashville, Tennessee
Texas Neurology, P.A. (110)
Dallas, Texas
Children's Medical Center Dallas (147)
Dallas, Texas
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.